MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) Style 15 Silicone Gel Filled Breast Implant; prosthesis, breast, noninflatable, internal, silicone gel-filled

Catalog Number	15-339
Medical Device Problem Codes	Gel Leak (1267); Device Appears to Trigger Rejection (1524)
Health Effect - Clinical Code	Capsular Contracture (1761)
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Clarification to d6a: partial date of 2011 provided.Continued e1: (b)(6).A review of the device history record has been completed.No deviations or non-conformances noted.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been/will be requested.No additional information is available at this time.Reason for reoperation: "implant bleeding"; capsular contracture, baker grade iv.
Event or Problem Description
Healthcare professional reported patient request as reason for removal.Healthcare professional later reported "implant 'bleeding'" and "capsular contracture", baker grade iv.Healthcare professional confirmed implant shell was intact.Capsulectomy was performed.This record is for the left side.The device has been explanted.
Event or Problem Description
Healthcare professional reported patient request as reason for removal.Healthcare professional later reported "implant 'bleeding'" and "capsular contracture", baker grade iv.Healthcare professional confirmed implant shell was intact.Capsulectomy was performed.This record is for the left side.The device has been explanted.
Additional Manufacturer Narrative
Lab results: per the investigation procedure, the device is analyzed through visual inspection microscopic inspection if openings are observed and a weight verification (if applicable).Per the analysis performed, the assessments of the complaints and any potential manufacturing issue are displayed along with any further actions required: gel bleed: not observed since the shell barrier can be observed through microscopic inspection.Capsular contracture: unable to observe through visual inspection as it is a physiological phenomenon.None of the other observations performed during the device analysis creases, opening, stress marks and wear abrasion are found to be potentially related to the manufacturing process, and, therefore, no further actions are required for these observations.

• Brand Name: Style 15 Silicone Gel Filled Breast Implant
• Common Device Name: prosthesis, breast, noninflatable, internal, silicone gel-filled
• Manufacturer (Section D): ALLERGAN (COSTA RICA); 900 parkway global park; zona franca; la aurora de heredia ; CS
• Manufacturer (Section G): Allergan (Costa Rica); 900 parkway global park; zona franca; la aurora de heredia ; CS
• Manufacturer Contact: terry ingram ; 2525 dupont drive; irvine, CA 92612 ; +1(847)936-6324
• MDR Report Key: 25578924
• Report Number: 9617229-2026-11762
• Device Sequence Number: 5152897
• Product Code: FTR
• UDI-Device Identifier: 10888628001466
• Combination Product (Y/N): N
• Initial Reporter State: UT
• Initial Reporter Country: US
• PMA/510(K) Number: P020056
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2011
• Device Explanted Year: 2026
• Reporter Type: Manufacturer
• Report Source: Health Professional
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 09/16/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 08/22/2015
• Device Catalogue Number: 15-339
• Device Lot Number: 2023079
• Was Device Available for Evaluation?: Yes
• Date Returned to Manufacturer: 08/20/2026
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Type of Report(Section G): Initial
• Initial Date Received by Manufacturer: 05/29/2026
• Supplement Date Received by Manufacturer: 08/29/2026
• Initial Report FDA Received Date: 06/22/2026
• Supplement Report FDA Received Date: 09/16/2026
• Was Device Evaluated by Manufacturer? (Y/N): Yes
• Date Device Manufactured: 09/22/2010
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Sex: Female
• Patient Weight: 124 LB
• Patient Race: White